Photo from wikipedia
Basal cell carcinoma (BCC) is the most frequent non‐melanoma skin cancer. The basis of treatment is surgical resection. The treatment of locally advanced and metastatic disease is currently based on… Click to show full abstract
Basal cell carcinoma (BCC) is the most frequent non‐melanoma skin cancer. The basis of treatment is surgical resection. The treatment of locally advanced and metastatic disease is currently based on sonidegb or vismodegib, small molecule inhibitors of the hedgehog signalling pathway.
Keywords:
vismodegib;
basal cell;
cell carcinoma
Journal Title: Journal of the European Academy of Dermatology and Venereology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the European Academy of Dermatology and Venereology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!